本日 1 人 - 昨日 10 人 - 累計 19258 人

2006

  1. HOME >
  2. 2006
• 氏家 寛: カンナビノイド受容体. 臨床精神医学 (2006) 35 229-231.

• 氏家 寛: アルコール・薬物依存症の遺伝子解析. 神経研究の進歩 (2006) 50 727-738.

• 氏家 寛: 全身疾患に精神疾患が由来する病態、甲状腺機能亢進症(subclinical hyperthyroidismを含む)症状性(器質性)精神障害の治療ガイドライン. 精神科治療学 (2006) 21 12-15.

• 氏家 寛: 全身疾患に精神疾患が由来する病態、甲状腺機能低下症(subclinical hypothyroidismを含む)症状性(器質性)精神障害の治療ガイドライン. 精神科治療学 (2006) 21 16-19.

• 氏家 寛: 特定の物質の不足ないしは過剰に疾患が由来する病態、コカイン症状性(器質性)精神障害の治療ガイドライン. 精神科治療学 (2006) 21 162-163.

• 氏家 寛、堀 達、小宮山徳太郎: 違法ドラッグを含む多剤乱用の実態と物質性誘発性精神病の遺伝子ファクター. 医学のあゆみ (2006) 217 1175-1179.

• 氏家 寛: 薬物依存、生物学的側面 . 精神科臨床ニューアプローチ8、睡眠障害・物質関連障害(上島国利編). "メディカルレビュー," 東京 (2006) 174-181.

• 氏家 寛、岸本真希子、森田幸孝、大谷恭平、岡久祐子、森尾亜希子、稲田俊也、原野陸正、小宮山徳太郎、 堀 達、山田光彦、 関根吉統、 曽良一郎、岩田仲生、 伊豫雅臣、尾崎紀夫、黒田重利: "多剤乱用の実態と物質誘発性精神病の遺伝子リスクファクターの解明、FZD-3, XBP-1およびFAAH遺伝子の検討." 平成17年度総括研究報告書 厚生労働科学研究費補助金(医薬品・医療機器等レギュラトリーサイエンス総合研究推進事業)研究「依存性薬物および未規制薬 物による神経毒性と精神病の発現機序」. (2006) 111-122.

• 大谷恭平、氏家 寛: 慢性統合失調症における抗精神病薬の有効性(海外文献紹介). Schizophrenia Frontier (2006) 7 67

• 岡崎祐士、曽良一郎、前田久雄、融 道男、台 弘、氏家 寛、福田正人、松岡洋夫、米田 博、小澤寛樹、倉知正佳: 遺伝子改変マウスを含めた統合失調症の動物モデル研究、Discussion. 臨床精神薬理 (2006) 9 1703?1713 .

• 岸本真希子、氏家 寛: DTNBP1遺伝子ハイリスクハプロタイプと統合失調症の臨床特性との関連(海外文献紹介). Schizophrenia Frontier (2006) 7 67-68.

• 黒田重利、来住由樹、原田俊樹、児玉匡史、氏家 寛、武田俊彦: 患者のタイプ別にみたクエチアピンの有効性. Pharma Medica (2006) 24 85-100.

• 森尾亜希子、氏家 寛: 合失調症における選択的な視床神経核でのドーパミン異常;細胞内シグナル調整タンパクcalcyon とspinophilinの含有量(海外文献紹介). Schizophrenia Frontier (2006) 7 68-69.

• 齋藤清子、寺田整司、氏家 寛、黒田重利: 全身疾患に精神疾患が由来する病態、Adrenoleucodystrophy症状性(器質性)精神障害の治療ガイドライン. 精神科治療学 (2006) 21 118-119.

• Ujike H, Sakai A, Nakata K, Tanaka Y, Kodaka T, Okahaisa Y, Harano M, Inada T, Yamada M, Komiyama T, Hori T, Sekine Y, Iwata N, Sora I, Iyo M, Ozaki N, Kuroda S: Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis. "In Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity, Cocaine, GHB, and Substituted Amphetamines. ." "Ed by Ali SF & Fornai F," "Ann N Y Acad Sci.," N.Y (2006) 90-96.

• Kobayashi H, Hata H, Ujike H, Harano M, Inada T, Komiyama T, Yamada M, Sekine Y, Iwata N, Iyo M, Ozaki N, Itokawa M, Naka M, Ide S, Ikeda K, Numachi Y, Sora I: Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence/psychosis.. Am J Med Genet B Neuropsychiatr Genet. (2006) 482-486.

• Kobayashi H, Ujike H, Hasegawa J, Yamamoto M, Kanzaki A, Sora I: Correlation of tau gene polymorphism with age at onset of Parkinson's disease. Neurosci Lett. (2006) 405 202-206 .

• Morita Y, Ujike H, Tanaka Y, Otani K, Kishimoto M, Morio A, Kotaka T, Okahisa Y, Morikawa A, Hamase K, Zaitsu K, Kuroda S: A genetic variant of the serine racemase gene is associated with schizophrenia. Neuroscience Abstract (2006) 588 21

• Nomura A, Ujike H, Tanaka Y, Otani K, Morita Y, Kishimoto M, Morio A, Harano M, Inada T, Yamada M, Komiyama T, Sekine Y, Iwata N, Sora I, Iyo M, Ozaki N, Kuroda S:" Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence. Neurosci Lett. (2006) 400 158-162.

• Zabetian CP, Morino H, Ujike H, Yamamoto M, Oda M, Maruyama H, Izumi Y, Kaji R, Griffith A, Leis BC, Roberts JW, Yearout D, Samii A, Kawakami H.: Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease.. Neurology. (2006) 67 697-699.

• Morio A, Ujike H, Nomura A, Tanaka Y, Morita Y, Otani K, Kishimoto M, Harano M, Inada T, Komiyama T, Yamada M, Hori T, Sekine Y, Iwata N, Iyo M, Sora I, Ozaki N, Kuroda S: No association between CART (Cocaine- and Amphetamine-Regulated Transcript) gene and methamphetamine dependence. "In Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity, Cocaine, GHB, and Substituted Amphetamines. ." "Ed by Ali SF & Fornai F," "Ann N Y Acad Sci.," N.Y (2006) 411-417.

• Nomura A, Ujike H, Tanaka Y, Kishimoto M, Otani K, Morita Y, Morio A, Harano M, Inada T, Yamada M, Komiyama T, Hori T, Sekine Y, Iwata N, Sora I, Iyo M, Ozaki N, Kuroda S: Association study of the tumor necrosis factor-αgene and its 1A receptor gene with methamphetamine dependence. "In Cellular and Molecular Mechanisms of Drugs of Abuse and Neurotoxicity, Cocaine, GHB, and Substituted Amphetamines. ." "Ed by Ali SF & Fornai F," "Ann N Y Acad Sci.," N.Y (2006) 116-124.

• Kishimoto M, Ujike H, Tanaka Y, Otani K, Morita Y, Morio A, Okahisa Y, Kotaka T, Harano M, Inada T, Yamada M, Komiyama T, Hori T, Sekine Y, Iwata N, Sora I, Iyo M, Ozaki N, Kuroda S: The Frizzled 3 (FZD3) gene is associted with methamphetamine psychosis. Am J Med Genet (2006) "141B, " 807

• Okahisa Y, Ujike H, Tanaka Y, Otani K, Morita Y, Kishimoto M, Morio A, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Sekine Y, Iwata N, Iyo M, Sora I, Ozaki N, Kuroda S: Association study between the NrCAM gene and patients with methamphetamine use diorders.. Am J Med Genet (2006) "141B, " 806-807.

• Okahisa Y, Ujike H, Tanaka Y, Otani K, Morita Y, Kishimoto M, Ozaki N, Kuroda S: Association study between the NRCAM gene and methamphetmaine userCollegium Internationale Neiro-Psychopharmacologicum . Asia Pacific Regional Meeting (2006) 59-60.

• Nakamura K, Chen CK, Sekine Y, Iwata Y, Anitha A, Loh el-W, Takei N, Suzuki A, Kawai M, Takebayashi K, Suzuki K, Minabe Y, Tsuchiya K, Yamada K, Iyo M, Ozaki N, Inada T, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Ball DM, Yoshikawa T, Lin SK, Mori N: Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations.. Hum Genet. (2006) 120 243-252.

• Suzuki A, Nakamura K, Sekine Y, Minabe Y, Takei N, Suzuki K, Iwata Y, Kawai M, Takebayashi K, Matsuzaki H, Iyo M, Ozaki N, Inada T, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Mori N: An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder.. Psychiatr Genet. (2006) 16 133-138.

• Aoyama N, Takahashi N, Kitaichi K, Ishihara R, Saito S, Maeno N, Ji X, Takagi K, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iwata N, Inada T, Ozaki N: Association Between Gene Polymorphisms of SLC22A3 and Methamphetamine Use Disorder.. Alcohol Clin Exp Res. (2006) 30 1644-1649.

• Arai M, Yamada K, Toyota T, Obata N, Haga S, Yoshida Y, Nakamura K, Minabe Y, Ujike H, Sora I, Ikeda K, Mori N, Yoshikawa T, Itokawa M: Association Between Polymorphisms in the Promoter Region of the Sialyltransferase 8B (SIAT8B) Gene and Schizophrenia.. Biol Psychiatry. (2006) 59 652-659 .

• Fujii K, Maeda K, Hikida T, Mustafa AK, Balkissoon R, Xia J, Yamada T, Ozeki Y, Kawahara R, Okawa M, Huganir RL, Ujike H, Snyder SH, Sawa A: Serine racemase binds to PICK1: potential relevance to schizophrenia.. Mol Psychiatry. (2006) 11 150-157.

• Ide S, Kobayashi H, Ujike H, Ozaki N, Sekine Y, Inada T, Harano M, Komiyama T, Yamada M, Iyo M, Iwata N, Tanaka K, Shen H, Iwahashi K, Itokawa M, Minami M, Satoh M, Ikeda K, Sora I: Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms.. Pharmacogenomics J. (2006) 6 179-188.

• Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshiya Y, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Inada T, Ozaki N: Positive association of AKT1 haplotype to Japanese methamphetamine use disorder.. Int J Neuropsychopharmacol. (2006) 9 77-81.

• Ishiguro H, Liu QR, Gong JP, Hall FS, Ujike H, Morales M, Sakurai T, Grumet M, Uhl GR.Related Articles, Links : NrCAM in Addiction Vulnerability: Positional Cloning, Drug-Regulation, Haplotype-Specific Expression, and Altered Drug Reward in Knockout Mice.. Neuropsychopharmacology. (2006) 31 572-584.